Skip to main content
Charles Daley, MD, Pulmonology, Denver, CO

CharlesLDaleyMD

Pulmonology Denver, CO

Infectious Disease

Professor, Medicine, National Jewish Health

Dr. Daley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Daley's full profile

Already have an account?

  • Office

    1400 Jackson St
    Denver, CO 80206
    Phone+1 303-388-4461
    Fax+1 303-270-2206

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1994 - 1997
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1983 - 1987
  • University of Mississippi School of Medicine
    University of Mississippi School of MedicineClass of 1983

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2004 - 2025
  • CA State Medical License
    CA State Medical License 1985 - 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Top Doctors Castle Connolly, 2013-2022
  • Top Doc US News and World Report, 2012-2017
  • World Lung Health Award American Thoracic Society, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis  
    Mark L Metersky, Charles L Daley, The New England Journal of Medicine

Lectures

  • The Denver TB Course 
    National Jewish Health, Denver, Colorado - 4/10/2013
  • 3rd Symposium on IGRAs 
    University of California San Diego, Waikoloa, Hawaii - 1/12/2012

Other

Press Mentions

  • A Modified BPaL Regimen for Tuberculosis Treatment Replaces Linezolid with Inhaled Spectinamides
    A Modified BPaL Regimen for Tuberculosis Treatment Replaces Linezolid with Inhaled SpectinamidesOctober 8th, 2024
  • National Jewish Health Develops Antibiogram to Help Providers Treat Nontuberculous Mycobacteria
    National Jewish Health Develops Antibiogram to Help Providers Treat Nontuberculous MycobacteriaFebruary 2nd, 2023
  • What Happened to Spice? Dangers of Plastic Surgery in the DR
    What Happened to Spice? Dangers of Plastic Surgery in the DRNovember 16th, 2022
  • Join now to see all

Professional Memberships

  • Member
  • Chest
    Fellow
  • Infectious Diseases Society of America
    Member
  • International Union Against Tuberculosis and Lung Disease
    Member